Jump to navigation
Tech Launch Arizona, the university's commercialization arm, recorded 303 novel inventions between July 1, 2021, and June 30 – the most invention disclosures registered for a single year in UArizona history.
Researchers have developed a new class of drugs that is able to cross the blood-brain barrier. The technology has been licensed to the startup Teleport Pharmaceuticals.
Funding from the Centers for Disease Control and Prevention will allow research that started by analyzing COVID-19 immunity and vaccine effectiveness in frontline workers to continue as new variants emerge.
The Center for Advanced Molecular and Immunological Therapies will support research to catalyze the next generation of precision health care treatments, building on the idea that the most effective defense against health issues is the body's natural immune system.
With a startup called CarbeniumTec, researchers in the College of Science and the College of Medicine – Tucson aim to bring to market new technology that reimagines how electricity is stored.
Parkinson's disease is perhaps best known for its movement-related symptoms, but it can also hinder vocal production. New research suggests that a specific gene commonly associated with Parkinson's may be behind those vocal issues – a finding that could help lead to earlier diagnosis and treatment for Parkinson's patients.
The partnership will advance pain and addiction research and accelerate positive health outcomes in Arizona, Oklahoma and across the country.
The Arizona Board of Regents confirmed the appointments of Sama Alshaibi, Jean-Luc Brédas, Dr. Juanita Merchant, David Pietz and Dr. Donata Vercelli as Regents Professors.
Friends and family gather to honor and celebrate College of Medicine – Tucson and College of Medicine – Phoenix medical students.
Arizona leads the nation in enrolling participants in the National Institutes of Health's All of Us Research Program.
